Improving Detection of CAD and Prognosis with PET/CT Quantitative Absolute Myocardial Blood Flow Measurements
Vincent Ngo1, Patrick Martineau2,3, Francois Harel1
1Department of Medical Imaging, Montreal Heart Institute, 5000 Belanger, Montreal, QC, H1C1C8, Canada.
Purpose Of Review:
The purpose of this review is to provide an overview of the role of PET MPI in the detection of CAD, focussing on the added value of MBF for diagnosis and prognostication.
Recent Findings:
Positron emission tomography (PET) myocardial perfusion imaging (MPI) is increasingly used for the risk stratification of patients with suspected or established coronary artery disease (CAD). PET MPI provides accurate and reproducible non-invasive quantification of myocardial blood flow (MBF) at rest and during hyperemia, providing incremental information over conventional myocardial perfusion alone. Inclusion of MBF in PET MPI interpretation improves both its sensitivity and specificity. Moreover, quantitative MBF measurements have repeatedly been shown to offer incremental and independent prognostic information over conventional clinical markers in a broad range of conditions, including in CAD. Quantitative MBF measurement is now an established and powerful tool enabling accurate risk stratification and guiding patients' management. The role of PET MPI and flow quantification in cardiac allograft vasculopathy (CAV), which represents a particular form of CAD, will also be reviewed.
Insights
Positron emission tomography myocardial perfusion imaging (PET MPI) with myocardial blood flow (MBF) quantification enhances coronary artery disease (CAD) detection and patient risk stratification. This method offers improved diagnostic accuracy and prognostic value for guiding clinical management.
Area of Science:
- Cardiology
- Nuclear Medicine
- Medical Imaging
Background:
- Positron emission tomography myocardial perfusion imaging (PET MPI) is a key tool for assessing coronary artery disease (CAD).
- Accurate risk stratification is crucial for managing patients with suspected or established CAD.
Purpose of the Study:
- To review the role of PET MPI in detecting CAD.
- To highlight the diagnostic and prognostic benefits of myocardial blood flow (MBF) quantification in PET MPI.
Main Methods:
- Review of current literature on PET MPI and MBF quantification in CAD.
- Focus on the incremental value of MBF measurements over conventional perfusion imaging.
Main Results:
- PET MPI with MBF quantification improves sensitivity and specificity for CAD detection.
- Quantitative MBF measurements provide independent prognostic information.
- MBF quantification aids in risk stratification and patient management.
Conclusions:
- PET MPI incorporating MBF quantification is a powerful tool for CAD diagnosis and prognostication.
- This approach enhances clinical decision-making for patients with CAD.
- The review also addresses the application of PET MPI and flow quantification in cardiac allograft vasculopathy (CAV).
More Related Videos
11:09High-Resolution Cardiac Positron Emission Tomography/Computed Tomography for Small Animals
Published on: December 16, 2022
08:13In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography
Published on: February 16, 2016
Related Concept Videos
Imaging Studies for Cardiovascular System V: CT
Acute Coronary Syndrome III: Diagnostic Studies
Positron Emission Tomography
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
![Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography FDG-PET/CT](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F3777.jpg&w=3840&q=50)